Suchergebnisse - "Wada, Kazuteru"

PubPharm (14)

1

AEROSOL-TYPE HAIR-DYEING OR DECOLORIZING/DESTAINING OXIDIZER-CONTAINING COMPOSITION

enthalten in: Europäisches Patentamt | 2021

von WADA KAZUTERU | YAMAGUCHI SHINGO | YASUDA TAKAHIRO

2

Sarilumab monotherapy or in combination with non-methotrexate disease-modifying antirheumatic drugs in active rheumatoid arthritis : A Japan phase 3 trial (HARUKA)

enthalten in: Modern rheumatology | 2020

von Kameda, H. | Wada, K. | Takahashi, Y. | +4

3

Correction to : Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan

enthalten in: Arthritis research & therapy | 2019

von Tanaka, Y. | Wada, K. | Takahashi, Y. | +4

ErratumFor: Arthritis Res Ther. 2019 Mar 20;21(1):79. - PMID 30894208

4

Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan

enthalten in: Arthritis Research & Therapy | 2019

von Tanaka, Y. | Wada, K. | Takahashi, Y. | +4

5

Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan

enthalten in: Arthritis Research & Therapy | 2019

von Tanaka, Y. | Wada, K. | Takahashi, Y. | +4

6

Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate : results of a randomized, placebo-controlled phase III trial in Japan

enthalten in: Arthritis research & therapy | 2019

von Tanaka, Y. | Wada, K. | Takahashi, Y. | +4

ErratumIn: Arthritis Res Ther. 2019 Apr 16;21(1):99. - PMID 30992058

7

Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan

enthalten in: Arthritis Research & Therapy | 2019

von Tanaka, Y. | Wada, K. | Takahashi, Y. | +4

8

Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan

enthalten in: Arthritis Research & Therapy | 2019

von Tanaka, Y. | Wada, K. | Takahashi, Y. | +4

9

Synthesis and biological activities of 1-pyridylisoquinoline and 1-pyridyldihydroisoquinoline derivatives as PDE4 inhibitors

enthalten in: Bioorganic & medicinal chemistry letters | 2003

von Ukita, T. | Sugahara, M. | Terakawa, Y. | +6

10

Synthesis and biological activities of 1-pyridylisoquinoline and 1-pyridyldihydroisoquinoline derivatives as PDE4 inhibitors

enthalten in: Bioorganic & medicinal chemistry letters | 2003

von Ukita, T. | Sugahara, M. | Terakawa, Y. | +6